How to Buy lykalabs Shares on Fincept?
You can buy Lyka Labs Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Lyka Labs Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Lykalabs, including updates on board meetings and corporate actions.
Lyka Labs Limited - https://www.lykalabs.com
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Lyka Labs Limited Share Price Today
149.70
OPEN
151.71
HIGH
144.00
LOW
145.26
CLOSE
56 K
VOLUME
531 Cr
Market Cap
194261
Average Volume
Healthcare
Sector
NSI
Exchange
Lyka Labs Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: LYKALABS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Lyka Labs Limited |
LYKALABS |
INE933A01014 |
Annual General Meeting |
01 Aug 2024 |
10 |
N/A |
Lyka Labs Limited |
LYKALABS |
INE933A01014 |
Annual General Meeting |
21 Jul 2023 |
10 |
N/A |
Lyka Labs Limited |
LYKALABS |
INE933A01014 |
Annual General Meeting |
21 Jul 2022 |
10 |
N/A |
Lyka Labs Limited |
LYKALABS |
INE933A01014 |
Annual General Meeting |
22 Jul 2021 |
10 |
N/A |
Lyka Labs Limited |
LYKALABS |
INE933A01014 |
Annual General Meeting |
16 Sep 2020 |
10 |
N/A |
NSE: LYKALABS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
LYKALABS |
02 Jan 2025, 17:33:02 |
Updates |
Pharmaceuticals |
LYKALABS |
30 Dec 2024, 13:56:40 |
Board Meeting Intimation |
Pharmaceuticals |
LYKALABS |
19 Dec 2024, 15:58:32 |
Trading Window-XBRL |
Pharmaceuticals |
LYKALABS |
19 Dec 2024, 15:55:28 |
Trading Window |
Pharmaceuticals |
LYKALABS |
02 Dec 2024, 18:13:29 |
Loss/Duplicate-Share Certificate-XBRL |
Pharmaceuticals |
NSE: LYKALABS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Lyka Labs Limited |
LYKALABS |
07 Jan 2025, 13:28:00 |
07 Jan 2025, 13:28:00 |
|
Lyka Labs Limited |
LYKALABS |
14 Oct 2024, 17:57:00 |
14 Oct 2024, 17:57:00 |
|
Lyka Labs Limited |
LYKALABS |
19 Jul 2024, 15:05:00 |
19 Jul 2024, 15:05:00 |
|
Lyka Labs Limited |
LYKALABS |
20 Apr 2024, 17:49:00 |
05 Feb 2025, 21:33:38 |
|
Lyka Labs Limited |
LYKALABS |
19 Jan 2024, 19:45:00 |
19 Jan 2024, 20:15:00 |
NSE: LYKALABS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director,Chairperson & Non-Executive Director |
16 Jan 1951 |
08 Aug 2022 |
00016573 |
BABU LAL JAIN |
- |
Executive Director-CEO-MD |
05 Apr 1987 |
12 Feb 2019 |
01516156 |
KUNAL NARENDRA GANDHI |
Active |
Non-Executive Director |
16 Nov 1974 |
08 Aug 2022 |
00012759 |
PRASHANT PREMCHAND GODHA |
Active |
Non-Executive Director |
15 May 1972 |
08 Aug 2022 |
09667654 |
SHASHIL PHILIP MENDONSA |
Active |
Independent Director |
22 Nov 1987 |
04 Aug 2021 |
07530998 |
DHARA PRATIK SHAH |
Active |
NSE: LYKALABS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
LYKA LABS LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
LYKALABS |
N/A |
INE933A01014 |
Lyka Labs Limited |
22 Oct 2024, 17:49:32 |
LYKA LABS LIMITED has informed the Exchange about Board Meeting to be held on 11-Oct-2024 to consider Amalgamation. |
LYKALABS |
N/A |
INE933A01014 |
Lyka Labs Limited |
04 Oct 2024, 12:38:55 |
Financial Results/Other business matters |
LYKALABS |
N/A |
INE933A01014 |
Lyka Labs Limited |
01 Aug 2024, 20:12:59 |
LYKA LABS LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. |
LYKALABS |
N/A |
INE933A01014 |
Lyka Labs Limited |
10 May 2024, 11:29:17 |
LYKA LABS LIMITED has informed the Exchange about Board Meeting to be held on 16-Apr-2024 to consider Other business. |
LYKALABS |
N/A |
INE933A01014 |
Lyka Labs Limited |
08 Apr 2024, 18:04:02 |
NSE: LYKALABS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
LYKALABS |
- |
INE933A01014 |
Lyka Labs Limited |
30 Dec 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2024 |
Financial Results |
LYKALABS |
- |
INE933A01014 |
Lyka Labs Limited |
30 Dec 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2024 |
Financial Results |
LYKALABS |
- |
INE933A01014 |
Lyka Labs Limited |
30 Dec 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2024 |
Financial Results |
LYKALABS |
- |
INE933A01014 |
Lyka Labs Limited |
22 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Other business matters |
LYKALABS |
- |
INE933A01014 |
Lyka Labs Limited |
04 Oct 2024, 00:00:00 |
To consider other business matters i.e. Notice of the Board Meeting for filling fresh application of Amalgamation of Lyka Exports Limited (Company s subsidiary) with the Company |
NSE: LYKALABS Balance Sheet Data In (Cr)
| date | period_type | Preferred Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Preferred Securities Outside Stock Equity | Non Current Pension And Other Postretirement Benefit Plans | Non Current Accrued Expenses | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 35,690,000.00 | 35,690,000.00 | 323,897,000.00 | 351,597,000.00 | 883,107,000.00 | 1,324,111,000.00 | 189,937,000.00 | 883,107,000.00 | 16,594,000.00 | 989,108,000.00 | 1,222,038,000.00 | 986,861,000.00 | -2,247,000.00 | 989,108,000.00 | 632,208,000.00 | 0.00 | 0.00 | 356,900,000.00 | 356,900,000.00 | 695,634,000.00 | 299,068,000.00 | 0.00 | 0.00 | 11,431,000.00 | 0.00 | 39,177,000.00 | 236,940,000.00 | 4,010,000.00 | 232,930,000.00 | 0.00 | 396,566,000.00 | 17,592,000.00 | 114,657,000.00 | 12,584,000.00 | 102,073,000.00 | 16,094,000.00 | 0.00 | 160,521,000.00 | 0.00 | 160,521,000.00 | 1,682,495,000.00 | 1,095,993,000.00 | 63,032,000.00 | 10,615,000.00 | 0.00 | 168,225,000.00 | 168,225,000.00 | 0.00 | 106,001,000.00 | 106,001,000.00 | 0.00 | 748,120,000.00 | 0.00 | 748,120,000.00 | 275,196,000.00 | 472,924,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 586,503,000.00 | 44,803,000.00 | 0.00 | 0.00 | 96,932,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 585,000.00 | 0.00 | 377,833,000.00 | 0.00 | 0.00 | 66,350,000.00 | 55,244,000.00 | 11,106,000.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 0.00 | 33,090,000.00 | 33,090,000.00 | 553,617,000.00 | 576,994,000.00 | 562,442,000.00 | 1,237,731,000.00 | 130,120,000.00 | 562,442,000.00 | 20,806,000.00 | 681,543,000.00 | 1,099,802,000.00 | 682,654,000.00 | 1,111,000.00 | 681,543,000.00 | 90,674,000.00 | -1,381,471,000.00 | 1,544,197,000.00 | 330,900,000.00 | 330,900,000.00 | 884,588,000.00 | 508,186,000.00 | 2,000.00 | 10,808,000.00 | 18,222,000.00 | 49,000.00 | 38,276,000.00 | 430,843,000.00 | 12,584,000.00 | 418,259,000.00 | 18,222,000.00 | 376,402,000.00 | -2,000.00 | 146,151,000.00 | 8,222,000.00 | 137,929,000.00 | 15,163,000.00 | 15,163,000.00 | 172,494,000.00 | 51,466,000.00 | 121,028,000.00 | 1,567,242,000.00 | 1,060,720,000.00 | -2,000.00 | 229,656,000.00 | 0.00 | 747,000.00 | 746,000.00 | 1,000.00 | 119,101,000.00 | 117,110,000.00 | 1,991,000.00 | 711,218,000.00 | -522,509,000.00 | 1,233,727,000.00 | 242,517,000.00 | 468,701,000.00 | 464,387,000.00 | 351,624,000.00 | 175,199,000.00 | 0.00 | 506,522,000.00 | 46,536,000.00 | 11,917,000.00 | 49,792,000.00 | 95,718,000.00 | 31,112,000.00 | 25,157,000.00 | 3,445,000.00 | 36,004,000.00 | 566,000.00 | 0.00 | 269,925,000.00 | -34,174,000.00 | 304,099,000.00 | 78,604,000.00 | 76,033,000.00 | 2,571,000.00 | 2,571,000.00 |
| 2024-03-31T00:00:00 | annual | 0.00 | 33,090,000.00 | 33,090,000.00 | 553,617,000.00 | 576,994,000.00 | 562,442,000.00 | 1,237,731,000.00 | 130,120,000.00 | 562,442,000.00 | 20,806,000.00 | 681,543,000.00 | 1,099,802,000.00 | 682,654,000.00 | 1,111,000.00 | 681,543,000.00 | 90,674,000.00 | -1,381,471,000.00 | 1,544,197,000.00 | 330,900,000.00 | 330,900,000.00 | 884,588,000.00 | 508,186,000.00 | 2,000.00 | 10,808,000.00 | 18,222,000.00 | 49,000.00 | 38,276,000.00 | 430,843,000.00 | 12,584,000.00 | 418,259,000.00 | 18,222,000.00 | 376,402,000.00 | -2,000.00 | 146,151,000.00 | 8,222,000.00 | 137,929,000.00 | 15,163,000.00 | 15,163,000.00 | 172,494,000.00 | 51,466,000.00 | 121,028,000.00 | 1,567,242,000.00 | 1,060,720,000.00 | -2,000.00 | 229,656,000.00 | 0.00 | 747,000.00 | 746,000.00 | 1,000.00 | 119,101,000.00 | 117,110,000.00 | 1,991,000.00 | 711,218,000.00 | -522,509,000.00 | 1,233,727,000.00 | 242,517,000.00 | 468,701,000.00 | 464,387,000.00 | 351,624,000.00 | 175,199,000.00 | 0.00 | 506,522,000.00 | 46,536,000.00 | 11,917,000.00 | 49,792,000.00 | 95,718,000.00 | 31,112,000.00 | 25,157,000.00 | 3,445,000.00 | 36,004,000.00 | 566,000.00 | 0.00 | 269,925,000.00 | -34,174,000.00 | 304,099,000.00 | 78,604,000.00 | 76,033,000.00 | 2,571,000.00 | 2,571,000.00 |
| 2023-09-30T00:00:00 | quarterly | 0.00 | 33,090,000.00 | 33,090,000.00 | 473,881,000.00 | 540,629,000.00 | 520,524,000.00 | 1,197,773,000.00 | 167,755,000.00 | 520,524,000.00 | 25,026,000.00 | 682,170,000.00 | 1,128,248,000.00 | 682,392,000.00 | 222,000.00 | 682,170,000.00 | 351,270,000.00 | 0.00 | 0.00 | 330,900,000.00 | 330,900,000.00 | 836,147,000.00 | 534,003,000.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 34,835,000.00 | 462,672,000.00 | 16,594,000.00 | 446,078,000.00 | 24,326,000.00 | 302,144,000.00 | 12,927,000.00 | 77,957,000.00 | 8,432,000.00 | 69,525,000.00 | 0.00 | 13,401,000.00 | 121,783,000.00 | 0.00 | 121,783,000.00 | 1,518,539,000.00 | 1,048,640,000.00 | 21,930,000.00 | 0.00 | 0.00 | 165,756,000.00 | 165,756,000.00 | 0.00 | 161,646,000.00 | 161,646,000.00 | 0.00 | 641,937,000.00 | 0.00 | 641,937,000.00 | 170,842,000.00 | 471,095,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 469,899,000.00 | 36,096,000.00 | 0.00 | 0.00 | 79,835,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 710,000.00 | 0.00 | 293,793,000.00 | 0.00 | 0.00 | 59,465,000.00 | 17,743,000.00 | 41,722,000.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 0.00 | 30,690,000.00 | 30,690,000.00 | 673,520,000.00 | 736,823,000.00 | 247,871,000.00 | 1,155,345,000.00 | 116,058,000.00 | 247,871,000.00 | 35,884,000.00 | 454,406,000.00 | 1,077,656,000.00 | 456,707,000.00 | 2,301,000.00 | 454,406,000.00 | 174,376,000.00 | -1,356,577,000.00 | 1,233,397,000.00 | 306,900,000.00 | 306,900,000.00 | 1,058,521,000.00 | 732,541,000.00 | 0.00 | 10,776,000.00 | 24,379,000.00 | 81,000.00 | 40,102,000.00 | 647,915,000.00 | 24,665,000.00 | 623,250,000.00 | 24,379,000.00 | 325,980,000.00 | -1,000.00 | 88,908,000.00 | 11,219,000.00 | 77,689,000.00 | 12,044,000.00 | 12,044,000.00 | 173,916,000.00 | 79,860,000.00 | 94,056,000.00 | 1,515,228,000.00 | 1,073,190,000.00 | 1,000.00 | 228,688,000.00 | 0.00 | 399,000.00 | 398,000.00 | 1,000.00 | 206,535,000.00 | 204,329,000.00 | 2,206,000.00 | 637,568,000.00 | -484,233,000.00 | 1,121,801,000.00 | 151,918,000.00 | 485,651,000.00 | 443,173,000.00 | 351,511,000.00 | 175,199,000.00 | 0.00 | 442,038,000.00 | 1,000.00 | 89,689,000.00 | 30,138,000.00 | 69,543,000.00 | 25,907,000.00 | 13,671,000.00 | 7,081,000.00 | 22,884,000.00 | 818,000.00 | 0.00 | 201,257,000.00 | -34,635,000.00 | 235,892,000.00 | 140,282,000.00 | 112,863,000.00 | 27,419,000.00 | 27,419,000.00 |
| 2023-03-31T00:00:00 | annual | 0.00 | 30,690,000.00 | 30,690,000.00 | 673,520,000.00 | 736,823,000.00 | 247,871,000.00 | 1,155,345,000.00 | 116,058,000.00 | 247,871,000.00 | 35,884,000.00 | 454,406,000.00 | 1,077,656,000.00 | 456,707,000.00 | 2,301,000.00 | 454,406,000.00 | 174,376,000.00 | -1,356,577,000.00 | 1,233,397,000.00 | 306,900,000.00 | 306,900,000.00 | 1,058,521,000.00 | 732,541,000.00 | 0.00 | 10,776,000.00 | 24,379,000.00 | 81,000.00 | 40,102,000.00 | 647,915,000.00 | 24,665,000.00 | 623,250,000.00 | 24,379,000.00 | 325,980,000.00 | -1,000.00 | 88,908,000.00 | 11,219,000.00 | 77,689,000.00 | 12,044,000.00 | 12,044,000.00 | 173,916,000.00 | 79,860,000.00 | 94,056,000.00 | 1,515,228,000.00 | 1,073,190,000.00 | 1,000.00 | 228,688,000.00 | 0.00 | 399,000.00 | 398,000.00 | 1,000.00 | 206,535,000.00 | 204,329,000.00 | 2,206,000.00 | 637,568,000.00 | -484,233,000.00 | 1,121,801,000.00 | 151,918,000.00 | 485,651,000.00 | 443,173,000.00 | 351,511,000.00 | 175,199,000.00 | 0.00 | 442,038,000.00 | 1,000.00 | 89,689,000.00 | 30,138,000.00 | 69,543,000.00 | 25,907,000.00 | 13,671,000.00 | 7,081,000.00 | 22,884,000.00 | 818,000.00 | 0.00 | 201,257,000.00 | -34,635,000.00 | 235,892,000.00 | 140,282,000.00 | 112,863,000.00 | 27,419,000.00 | 27,419,000.00 |
| 2022-03-31T00:00:00 | annual | 0.00 | 28,690,000.00 | 28,690,000.00 | 1,263,895,000.00 | 1,292,448,000.00 | -127,614,000.00 | 1,410,746,000.00 | -471,545,000.00 | -127,614,000.00 | 15,087,000.00 | 133,385,000.00 | 741,885,000.00 | 134,910,000.00 | 1,525,000.00 | 133,385,000.00 | 1,000.00 | -1,224,460,000.00 | 974,397,000.00 | 286,900,000.00 | 286,900,000.00 | 1,721,234,000.00 | 727,707,000.00 | 2,000.00 | 7,774,000.00 | 0.00 | 15,273,000.00 | 42,334,000.00 | 617,086,000.00 | 8,586,000.00 | 608,500,000.00 | 34,688,000.00 | 993,527,000.00 | 32,500,000.00 | 675,362,000.00 | 6,501,000.00 | 668,861,000.00 | 10,469,000.00 | 10,470,000.00 | 204,617,000.00 | 65,290,000.00 | 139,327,000.00 | 1,856,144,000.00 | 1,334,162,000.00 | 2,000.00 | 213,362,000.00 | 0.00 | 89,000.00 | 88,000.00 | 1,000.00 | 260,999,000.00 | 260,999,000.00 | 0.00 | 859,710,000.00 | -507,337,000.00 | 1,367,047,000.00 | 166,076,000.00 | 693,636,000.00 | 445,271,000.00 | 444,369,000.00 | 311,331,000.00 | 0.00 | 521,982,000.00 | 6,375,000.00 | 157,039,000.00 | 70,039,000.00 | 81,981,000.00 | 42,005,000.00 | 4,793,000.00 | 3,879,000.00 | 31,304,000.00 | 445,000.00 | 0.00 | 184,527,000.00 | -35,186,000.00 | 219,713,000.00 | 27,951,000.00 | 14,485,000.00 | 13,466,000.00 | 13,466,000.00 |
| 2021-03-31T00:00:00 | annual | 108,570.00 | 28,690,000.00 | 28,690,000.00 | 1,610,319,000.00 | 1,626,339,000.00 | -660,836,000.00 | 1,354,712,000.00 | -208,005,000.00 | -660,836,000.00 | 13,660,000.00 | -257,967,000.00 | 1,245,519,000.00 | -250,924,000.00 | 7,043,000.00 | -257,967,000.00 | 0.00 | -1,614,456,000.00 | 974,397,000.00 | 286,900,000.00 | 286,900,000.00 | 2,151,047,000.00 | 1,652,238,000.00 | -1,000.00 | 7,068,000.00 | 36,624,000.00 | 88,245,000.00 | 0.00 | 1,509,416,000.00 | 5,930,000.00 | 1,503,486,000.00 | 36,624,000.00 | 498,809,000.00 | 32,911,000.00 | 116,923,000.00 | 7,730,000.00 | 109,193,000.00 | 17,004,000.00 | 2,672,000.00 | 340,408,000.00 | 119,613,000.00 | 220,795,000.00 | 1,900,123,000.00 | 1,609,319,000.00 | 14,145,000.00 | 201,732,000.00 | 163,460,000.00 | 89,000.00 | 88,000.00 | 1,000.00 | 402,869,000.00 | 402,869,000.00 | 0.00 | 839,985,000.00 | -389,867,000.00 | 1,229,852,000.00 | 165,219,000.00 | 35,094,000.00 | 386,086,000.00 | 379,207,000.00 | 299,340,000.00 | 0.00 | 290,804,000.00 | 6,396,000.00 | 69,177,000.00 | 60,973,000.00 | 43,062,000.00 | 18,917,000.00 | 1,890,000.00 | 2,677,000.00 | 19,578,000.00 | 17,373,000.00 | 0.00 | 86,721,000.00 | -35,360,000.00 | 122,081,000.00 | 7,102,000.00 | 4,742,000.00 | 2,360,000.00 | 2,360,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38,624,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 122,882,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 388,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: LYKALABS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Net Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -74,581,000.00 | 0.00 | 251,100,000.00 | -92,314,000.00 | 59,488,000.00 | 0.00 | 117,108,000.00 | -57,620,000.00 | 19,528,000.00 | 0.00 | -71,742,000.00 | 251,100,000.00 | 251,100,000.00 | -159,830,000.00 | 57,242,000.00 | 0.00 | -217,072,000.00 | -94,881,000.00 | 0.00 | -2,567,000.00 | -92,314,000.00 | 0.00 | -92,314,000.00 | 0.00 | 17,733,000.00 | -15,186,000.00 | -137,989,000.00 | -13,379,000.00 | -53,820,000.00 | 26,972,000.00 | -26,175,000.00 | -63,066,000.00 | 51,476,000.00 | 5,727,000.00 | 128,018,000.00 | 89,742,000.00 | 38,276,000.00 | -87,000.00 | -4,888,000.00 | 0.00 | -9,338,000.00 |
| 2023-03-31T00:00:00 | annual | 7,672,000.00 | 0.00 | 453,375,000.00 | -81,854,000.00 | 117,108,000.00 | 0.00 | 170,505,000.00 | -53,397,000.00 | -216,427,000.00 | 0.00 | -101,987,000.00 | 453,375,000.00 | 453,375,000.00 | -567,815,000.00 | -119,548,000.00 | 0.00 | -448,267,000.00 | 73,504,000.00 | 0.00 | 10,358,000.00 | 63,146,000.00 | 145,000,000.00 | -81,854,000.00 | 0.00 | 89,526,000.00 | 2,048,000.00 | -98,587,000.00 | -74,751,000.00 | 17,117,000.00 | -25,898,000.00 | 12,439,000.00 | -12,533,000.00 | 175,013,000.00 | 5,313,000.00 | 141,473,000.00 | 87,788,000.00 | 141,473,000.00 | -4,000.00 | -4,019,000.00 | 0.00 | -131,711,000.00 |
| 2022-03-31T00:00:00 | annual | 717,332,000.00 | 0.00 | 0.00 | -75,129,000.00 | 170,505,000.00 | 1,000.00 | 71,536,000.00 | 98,968,000.00 | -631,773,000.00 | -1,000.00 | -229,857,000.00 | 0.00 | 0.00 | -401,915,000.00 | 95,773,000.00 | 0.00 | -497,688,000.00 | -61,720,000.00 | 0.00 | 13,409,000.00 | -75,129,000.00 | 0.00 | -75,129,000.00 | 0.00 | 792,461,000.00 | -9,175,000.00 | -210,132,000.00 | -6,035,000.00 | -34,540,000.00 | -27,158,000.00 | -38,919,000.00 | -90,911,000.00 | 245,788,000.00 | 5,326,000.00 | 173,494,000.00 | 0.00 | 173,494,000.00 | -3,000.00 | -5,308,000.00 | 0.00 | 592,470,000.00 |
| 2021-03-31T00:00:00 | annual | 75,438,000.00 | -48,465,000.00 | 0.00 | -12,678,000.00 | 71,536,000.00 | -1,000.00 | 103,016,000.00 | -31,479,000.00 | -117,982,000.00 | 0.00 | -68,852,000.00 | 0.00 | 0.00 | -49,130,000.00 | -48,465,000.00 | -48,465,000.00 | -665,000.00 | -1,613,000.00 | 0.00 | 11,065,000.00 | -12,678,000.00 | 0.00 | -12,678,000.00 | -12,678,000.00 | 88,116,000.00 | -8,063,000.00 | -116,363,000.00 | -89,638,000.00 | 8,799,000.00 | -41,340,000.00 | 24,266,000.00 | -7,304,000.00 | 261,400,000.00 | 9,786,000.00 | 83,238,000.00 | 0.00 | 83,238,000.00 | -3,000.00 | -439,000.00 | 0.00 | -141,441,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | -18,292,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -18,292,000.00 | 0.00 | 0.00 | -1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10,984,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: LYKALABS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Impairment Of Capital Assets | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.00 | 0.00 | 16.56 | 0.00 | 0.00 | -2.49 | 12.80 | 45.19 | 16.56 | 3.76 | -3.95 | 4.69 | 0.86 | -2.49 | -2.49 | 102.58 | 1.70 | 3.30 | 3.30 | 0.00 | 0.00 | -2.49 | -2.49 | 0.00 | -2.49 | 0.13 | -2.62 | -2.62 | 1.69 | -0.93 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | -3.95 | 0.12 | 4.69 | 0.86 | 2.55 | 57.39 | 16.21 | 12.80 | 0.00 | 12.80 | 5.86 | 3.28 | 2.58 | 1.70 | 59.94 | 45.19 | 105.13 | 105.13 |
| 2023-03-31T00:00:00 | annual | -0.01 | 0.00 | 19.79 | -7.09 | -7.09 | -13.21 | 14.15 | 37.87 | 12.70 | -1.45 | -9.72 | 11.72 | 2.15 | -6.13 | -13.21 | 85.90 | 1.49 | 2.88 | 2.88 | 0.00 | 0.00 | -13.21 | -13.21 | 0.00 | -13.21 | -0.06 | -13.15 | -13.15 | -0.02 | -13.17 | 0.79 | -7.09 | 7.34 | -0.25 | 0.00 | -9.72 | 0.15 | 11.72 | 2.15 | 2.44 | 48.03 | 13.23 | 14.15 | 0.00 | 14.15 | 5.16 | 2.28 | 2.88 | 1.49 | 50.47 | 37.87 | 88.34 | 88.34 |
| 2022-03-31T00:00:00 | annual | -2.03 | 0.00 | 102.52 | -5.79 | -5.79 | 39.00 | 17.35 | 53.30 | 96.73 | 79.38 | -18.79 | 20.13 | 1.34 | 42.76 | 39.00 | 100.50 | 0.77 | 2.87 | 2.87 | 0.00 | 0.00 | 39.00 | 39.00 | 0.00 | 39.00 | 0.56 | 38.44 | 38.44 | 20.80 | 59.25 | 0.21 | -5.79 | 0.03 | 3.38 | 2.38 | -18.79 | 0.00 | 20.13 | 1.34 | 83.09 | 47.19 | 15.46 | 17.35 | 11.71 | 17.35 | 5.97 | 2.77 | 3.20 | 0.77 | 130.28 | 53.30 | 183.59 | 183.59 |
| 2021-03-31T00:00:00 | annual | -0.32 | 0.00 | 21.23 | -1.11 | -1.11 | -11.55 | 8.32 | 38.18 | 20.12 | 11.79 | -24.83 | 25.94 | 1.11 | -10.76 | -11.55 | 55.75 | 0.65 | 2.87 | 2.87 | 0.00 | 0.00 | -11.66 | -11.66 | 0.11 | -11.55 | -1.46 | -10.09 | -10.09 | -4.05 | -14.14 | 0.33 | -1.11 | 0.73 | 0.11 | 0.26 | -24.83 | 0.28 | 25.94 | 1.11 | 11.36 | 17.56 | 9.12 | 8.32 | 0.00 | 8.32 | 3.99 | 1.74 | 2.25 | 0.65 | 28.92 | 38.18 | 67.11 | 67.11 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 2.86 | 0.00 | 1.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
0.91
P/E
163.57143
P/B
7.226781
Dividend Yield
N/A
Market Cap
531.25 Cr.
Face Value
20.597
Book Value
20.597
ROE
0.7%
EBITDA Growth
15.46 Cr.
Debt/Equity
86.105
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of lykalabs?
The market capitalization of Lyka Labs Limited is ₹531 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Lyka Labs Limited?
The PE and PB ratios of Lyka Labs Limited are Not Available and 7.226781 respectively as of 05 Feb 2025.
What is the 52 Week High of Lyka Labs Limited?
The 52-week high of Lyka Labs Limited is ₹176.59 as of 05 Feb 2025.
What is the 52 Week Low of Lyka Labs Limited?
The 52-week low of Lyka Labs Limited is ₹97.9 as of 05 Feb 2025.
What are the earnings per share (EPS) for Lyka Labs Limited?
The Earnings Per Share (EPS) of Lyka Labs Limited is ₹0.91 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Lyka Labs Limited?
The Return on Equity (ROE) of Lyka Labs Limited is 0.7% as per the most recent financial year data. Explore more on Fincept.